Science and Technology Science and Technology
Mon, May 21, 2012

ON Semiconductor Selected by CVRx for Advanced Implantable Device Used in the Treatment of Hypertension


Published on 2012-05-21 08:10:13 - Market Wire
  Print publication without navigation


PHOENIX--([ ])--ON Semiconductor (Nasdaq: [ ONNN ]), a premier supplier of high-performance silicon solutions for energy efficient electronics, announced today that CVRx, a market-leading developer of proprietary active implantable technology to treat high blood pressure, is using its technology and manufacturing services. CVRx recently launched the Barostim neoa" a" the companyas second-generation implantable anti-hypertensive barostimulation device a" in Europe.

"Our selection of ON Semiconductor for the development of our latest implantable device for treating hypertension has had multiple benefits"

ON Semiconductoras extensive experience in designing and manufacturing analog, [ digital and mixed-signal ] semiconductor solutions for a wide range of [ medical applications ] helped CVRx achieve the required reliability and device performance during extensive pre-production testing. In addition, the use of ON Semiconductor design kits and intellectual property, as well as its layout and foundry services, compressed the development cycle.

The Barostim neo contains three ON Semiconductor devices. Two custom application-specific integrated circuits (ASICs) include a high-voltage analog C5 process device and a digital control ASIC manufactured using ON Semiconductoras I3T process, which supports digital integration, combined with mixed analog and smart power high-voltage structures. Also housed within the compact Barostim neo is an ON Semiconductor 8 megabit medical memory ASSP. All three devices achieve low-power operation to support long operational life a" a key requirement for implantable medical devices.

aOur selection of ON Semiconductor for the development of our latest implantable device for treating hypertension has had multiple benefits,a said Joe DuPay, vice president of Research & Development and Operations, CVRx, Inc. aBy combining our own core expertise with ON Semiconductoras knowledge, experience and product longevity support in the demanding medical semiconductor market, we shortened the product development cycle while setting the highest standards in very low-power, reliable design.a

About CVRx

CVRx, Inc. is a private company and is headquartered in Minneapolis. The company has developed the Barostim neo for the treatment of high blood pressure and heart failure. For more information, visit [ www.cvrx.com ].

About ON Semiconductor

ON Semiconductor (Nasdaq: ONNN) is a premier supplier of high-performance silicon solutionsfor energy efficient electronics. The company's broad portfolioof power and signal management, logic, discrete and custom devices helps customers efficiently solve theirdesign challengesin [ automotive, communications, computing, consumer, industrial, LED lighting, medical, military/aerospace and powerapplications ].ON Semiconductor operates aworld-class, value-added supply chain and a network of manufacturing facilities, sales offices and design centers in key markets throughout North America, Europe, and the Asia Pacific regions. For more information, visit [ http://www.onsemi.com ].

ON Semiconductor and the ON Semiconductor logo are registered trademarks of Semiconductor Components Industries, LLC. All other brand and product names appearing in this document are registered trademarks or trademarks of their respective holders. Although the company references its Web site in this news release, such information on the Web site is not to be incorporated herein.

Contributing Sources